Cardiovascular diseases

2022 Activity indicators

2 European IMI & H2020 projects
7 national public projects - ISCIII, CAM, MICINN
12 private projects led
5 private competitive projects led (SEC, UFV)
47 clinical trials led
1 competitive HR contract.
102 publications.
IF: 999,402
Publications in D1: 30 (29 %).
Q1 publications: 49 (48 %).
7 supervised doctoral theses read
2 awards/recognitions
3 European clinical practice guidelines (ESC)
4 Consensus documents
Members of Editorial Committees: 5 researchers
1 international patent (EP11845312,5) "Possible use of EMMPRIN inhibitors for the treatment of cardiac damage after ischaemia-reperfusion" (Authors: Carlos Zaragoza et al.)

Award of a new European project of the Horizon Europe research programme funded by the European Commission, STRATIFYHF- 101080905, "Artificial intelligence-based decision support system for risk stratification and early detection of heart failure in primary and secondary care".
Dr. José Luis Zamorano recognised as "Corresponding Academician of the RANME, Medal of the Academic Body and accrediting Diploma" by the Royal National Academy of Medicine.
Only Spanish public centre with more than 500 annual ablations in the Arrhythmia Unit, led by Dr. Javier Moreno".
Award of the ApSTEMI study (A double-blind, placebo-controlled, randomised, Phase II clinical study of ApTOLL for the treatment of ST Elevation Myocardial Infarction), with Dr. Zamorano as national coordinator and Dr. Sanmartín as PI at our centre.
Transversal research line of the service led by Dr. Rocío Hinojar. International leaders in percutaneous treatment of tricuspid regurgitation, with 37 Cardiobands implanted in the Haemodynamics Unit, led by Dr. Angel Sánchez Recalde.

	Articles	Accum. IF	Mean IF	Articles Q1 or Q2	% in Q1 or Q2	Articles D1	% in D1
2018	74	421,69	5,70	47	64	23	31
2019	73	427,45	5,86	40	55	14	19
2020	87	372,38	4,28	48	55	14	16
2021	95	637,15	6,71	73	77	20	21
2022	102	999,40	9,80	74	73	30	29
	431	2858,07	6,47	282	65	101	23